Hims & Hers Health, Inc.

NYSE:HIMS

Medical - Equipment & Services

Healthcare
$17.05 +3.47%

+$1.11 today

Market cap
$3.85B
Beta
2.40
P/E (TTM)
-569.3
EPS (TTM)
-$0.06
52W Low $13.74High $70.43

Volume 9.53M

Average 26.18M

HIMS Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Hims & Hers Health, Inc.NYSE: HIMS

Stock-Based Compensation · Q3 FY2026 · quarter ended Sep 2026

Stock-based compensation growth accelerates

Q3 FY2026 stock-based compensation of $64.48M rose 60.5% year over year, ahead of the +42.2% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 53.1% from the prior quarter. Over 3 fiscal years it compounded at +46.7% a year.

Context

  • Stock-based compensation amounted to 5.8% of revenue in FY2025, down 0.5 pp from a year earlier.
  • Stock-based compensation increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +60.5% holds above the trailing-twelve-month pace of +42.2%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$64.48M+53.1% QoQ
Last fiscal yearDec 2025
$135.24M+46.5% YoY
LTMSep 2026
$177.94M+42.2% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+60.5%——
1 year+46.5%——
3-year CAGR+46.7%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
135.24M USD
Year-over-year change
+46.5%
4-year CAGR
+19.1%

Stock-Based Compensation vs competitors

How HIMS compares with its peers on the latest reported figures

  • HIMS's LTM Sep 2026 stock-based compensation of $177.94M is the 2nd largest of the 10 companies compared; the peer median is $21.1M.
  • Its year-over-year change of +42.2% is the 3rd highest of 9, against a peer median of -17.7%.
  • Stock-based compensation amounts to 6.2% of revenue for HIMS, versus a peer median of 1.2%.
HIMS Competitors Peer median
Stock-Based Compensation for HIMS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ELThe Estée Lauder Companies Inc.LTM Sep 2026$222M +152.3%—1.5%
HIMSHims & Hers Health, Inc.LTM Sep 2026$177.94M +42.2%+46.7%6.2%
ELFe.l.f. Beauty, Inc.LTM Jun 2026$96.73M +40.8%+44.0%5.5%
KVUEKenvue Inc.LTM Sep 2026$59M -63.1%-0.2%0.4%
PRGOPerrigo Company plcLTM Jun 2026$21.2M -17.8%—0.5%
COTYCoty Inc.LTM Sep 2026$21.1M -55.6%-30.2%0.4%
EPCEdgewell Personal Care CompanyLTM Mar 2026$21.1M -17.6%+1.0%1.0%
HNSTThe Honest Company, Inc.LTM Mar 2026$8.1M +80.2%-11.3%2.3%
LFMDLifeMD, Inc.LTM Mar 2026$7.95M -35.1%-8.6%3.6%
HELEHelen of Troy LimitedLTM Dec 2025$0 ———
Peer median (excluding HIMS) $21.1M-17.7%-4.4%1.2%

Competitors are the stored peer set for HIMS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(107.66M)(65.68M)(23.55M)126.04M128.37M
Depreciation & Amortization4.08M7.47M9.52M17.09M54.5M
Deferred Income Tax(3.39M)(594K)(13K)(61.65M)(12.96M)
Stock-Based Compensation67.21M42.82M66.08M92.32M135.24M
Change in Working Capital3.46M(14.2M)20.82M78.62M(29.16M)
Accounts Receivables00000
Inventory(9.63M)(8M)(902K)(41.61M)(13.72M)
Accounts Payables9.85M12.72M7.32M43.71M30.3M
Other Working Capital3.23M(18.91M)14.4M76.53M(45.74M)
Other Non-Cash Items1.89M3.65M626K(1.34M)24.02M
Operating Cash Flow(34.41M)(26.53M)73.48M251.08M300.01M
Capital Expenditures(5.01M)(7.25M)(26.49M)(52.75M)(226.05M)
Acquisitions (Net)(46.47M)(459K)0(15.4M)(145.23M)
Purchases of Investments(266.63M)(187.7M)(157.24M)(160.56M)(745.84M)
Sales of Investments161.84M230.11M171.63M209.67M108.7M
Other Investing Activities(4.18M)(4.53M)(9.27M)(11.1M)(16.55M)
Investing Cash Flow(156.27M)34.7M(12.11M)(19.05M)(1.02B)
Debt Repayment1.19M000918.78M
Common Stock Issued272.69M00017.47M
Common Stock Repurchased(22.03M)0(2M)(83.04M)(89.96M)
Dividends Paid00000
Other Financing Activities(16.81M)(33.13M)(9.48M)(24.81M)(116.67M)
Financing Cash Flow235.04M(33.13M)(11.48M)(107.85M)729.62M
Effect of Forex Changes(73K)(53K)(11K)(270K)3.36M
Net Change in Cash44.29M(25.01M)49.89M123.92M8.03M
Free Cash Flow(39.42M)(33.78M)46.99M198.33M73.96M

Hims & Hers Health, Inc.

NYSE:HIMS

Intrinsic Alpha fair value

Locked

Current Price

$17.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.